Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Dare Bioscience, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −1 vs. Q4 2024
- Shares held
- 827.0K
- +49.8K (+6.4%) vs. Q4 2024
- Total value
- $2.39M
- −$34.9K (−1.4%) vs. Q4 2024
- New holders
- 0
- 8 more added
- Sold out
- 1
- 3 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DARE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.75M |
| Q1 2026 | 25 | $1.87M |
| Q4 2025 | 27 | $1.90M |
| Q3 2025 | 21 | $2.12M |
| Q2 2025 | 23 | $2.16M |
| Q1 2025 | 24 | $2.39M |
| Q4 2024 | 25 | $2.43M |
| Q3 2024 | 22 | $2.08M |
| Q2 2024 | 28 | $2.46M |
| Q1 2024 | 36 | $3.35M |
| Q4 2023 | 35 | $2.04M |
| Q3 2023 | 30 | $5.97M |
| Q2 2023 | 28 | $5.92M |
| Q1 2023 | 29 | $7.16M |
| Q4 2022 | 30 | $5.82M |
| Q3 2022 | 31 | $7.56M |
| Q2 2022 | 36 | $9.12M |
| Q1 2022 | 40 | $9.89M |
| Q4 2021 | 38 | $13.7M |
| Q3 2021 | 37 | $8.07M |
| Q2 2021 | 34 | $6.40M |
| Q1 2021 | 30 | $6.10M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Dare Bioscience, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 328,328 | $948.9K | 0.00% | +39,703+13.8% | Added |
| AMH Equity Ltd | 164,302 | $474.8K | 0.73% | +14,302+9.5% | Added |
| Geode Capital Management, LLC | 95,905 | $277.2K | 0.00% | +3,252+3.5% | Added |
| Renaissance Technologies LLC | 70,595 | $204.0K | 0.00% | +1,900+2.8% | Added |
| Susquehanna International Group, LLP | 58,164 | $168.1K | 0.00% | +17,582+43.3% | Added |
| State Street Corp | 23,515 | $68.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 22,091 | $63.8K | 0.00% | −10,302−31.8% | Reduced |
| BlackRock, Inc. | 16,971 | $49.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 16,685 | $48.0K | 0.00% | +50+0.3% | Added |
| Northern Trust Corp | 15,044 | $43.5K | 0.00% | +74+0.5% | Added |
| Price T Rowe Associates Inc | 10,491 | $31.0K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1,667 | $5.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,442 | $4.17K | 0.00% | −194−11.9% | Reduced |
| Insight Financial Services | 950 | $2.75K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 575 | $1.66K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 87 | $252 | 0.00% | +4+4.8% | Added |
| Mather Group, LLC. | 84 | $243 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 42 | $121 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 25 | $72 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 19 | $55 | 0.00% | −2−9.5% | Reduced |
| Caldwell Sutter Capital, Inc. | 17 | $49 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 7 | $20 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 2 | $6 | 0.00% | 00.0% | Unchanged |
| Putney Financial Group LLC | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −16,584−100.0% | Sold out |